SKI Market

A+| A| A-|

Indian Indices

Sensex

77,100.47 109.25
( 0.14%)

Global Indices

Nasdaq

51,927.61 57.71
(0.11%)

Dow Jones

7,374.18 -5.04
(-0.07%)

Hang Seng

69,065.93 -3,300.41
(-4.56%)

Nikkei 225

10,536.79 75.16
(0.72%)

Forex

USD-INR

94.55 -0.19
(-0.20%)

EUR-INR

107.36 -0.64
(-0.59%)

GBP-INR

124.56 -0.65
(-0.52%)

JPY-INR

0.58 0.00
(-0.30%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sat Kartar Life Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

93343

INE0NB801022

42.9694562

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SATKARTAR

12.7

219.17

EPS(TTM)

Face Value()

Div & Yield %

10.96

Back

infosys ltd

Fredun Pharmaceuticals standalone net profit rises 96.62% in the December 2025 quarter

Feb 13,2026

Net profit of Fredun Pharmaceuticals rose 96.62% to Rs 10.48 crore in the quarter ended December 2025 as against Rs 5.33 crore during the previous quarter ended December 2024. Sales rose 57.04% to Rs 159.93 crore in the quarter ended December 2025 as against Rs 101.84 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	159.93	101.84	57
OPM %	16.46	12.98	-
PBDT	15.78	8.22	92
PBT	14.00	7.13	96
NP	10.48	5.33	97

77,100.47 109.25 ( 0.14%)

51,927.61 57.71 (0.11%)

7,374.18 -5.04 (-0.07%)

69,065.93 -3,300.41 (-4.56%)

10,536.79 75.16 (0.72%)

94.55 -0.19 (-0.20%)

107.36 -0.64 (-0.59%)

124.56 -0.65 (-0.52%)

0.58 0.00 (-0.30%)